Board summary
Key figures
58,006
Registered population
61.4% aged 18–64
12.2%
Aged 65+
ICB 20.0% · England 17.9%
39.7%
Ethnic minority (non-White)
35.8% Asian · England 9.6%
68.5%
In IMD quintile 1
ICB 30.6% · England 21.0%
~36,423
Core20 residents (est.)
Resident basis; registered basis ~40,782 · see page 3
8,100
Hypertension register
+5.61% in 3 yrs · England +5.60%
807
SMI register
32.3% of Blackburn with Darwen (LAD)'s
1,373
COPD register
Reviews -2.58% in 3 yrs
Forecast to 2030
9,211
Hypertension patients, 2030
+1,111 on today
76.8%
QRISK ≥20% on statins, 2030
+3.61pp over 3 yrs
2.6%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Hypertension target control trails England and is falling.
Treated-to-target blood pressure sits below England (70.3%) and Blackburn with Darwen (68.0%), having fallen 3.5% over 2023 to 2025 (England +3.6%).
Asthma annual reviews leave about 2,000 unreviewed.
Review coverage trails England (65.7%) and Blackburn with Darwen (63.5%), leaving 1,972 (about 2,000) of 4,557 registered asthma patients without a review.
Lipid therapy in high-risk cohorts exceeds England.
Lipid-lowering therapy for QRISK ≥ 20% exceeds England (63.6%), alongside 89.0% statin treatment in diabetes with CVD (England 84.4%) and 77.7% in CKD.
Population, age and ethnicity
A younger population and 35.8% Asian ethnicity may shape primary care demand
Across 58,006 registered patients, Blackburn East PCN has a younger age profile: 26.4% are aged 0-17, compared with 24.0% in Blackburn with Darwen (LAD), 19.6% in NHS Lancashire and South Cumbria Integrated Care Board, and 19.6% in England. Conversely, 12.2% are aged 65+, below the borough (13.5%), ICB (20.0%), and England (17.9%). Census usual residents indicate 35.8% are Asian / Asian British, compared with 35.7% in the borough, 9.4% in the ICB, and 9.6% in England. Paediatric demand may be higher, while ethnicity reflects area residents rather than GP registers.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackburn with Darwen (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackburn with Darwen LA) | 1,724 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 84.0% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 55.3% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackburn with Darwen LA) | 951 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackburn with Darwen LA) | 16.5 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 areas house 68.5% of registered patients, ranging from 50.1% to 92.5% across practices
Across the PCN, 68.5% of registered patients live in England's most deprived quintile (borough 59.6%, ICB 30.6%, England 21.0%), with an average IMD decile of 2.8. Concentration reaches 92.5% at William Hopwood Street Surgery, spanning a 42.3 pp range from St Georges Surgery (50.1%), while volume is largest at The Cornerstone Practice (13,638 estimated Core20 patients). Modelled weighted practice share is 70.3%, showing a 1.77 percentage point difference from PCN reporting. Resource planning must balance intensive outreach in high-concentration practices with capacity at high-volume sites.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
807
SMI register
1.39% recorded prevalence
415
Learning disability register
0.72% recorded prevalence
31
Care homes, 1,040 beds
In the PCN catchment
9.9%
Provide unpaid care
Blackburn with Darwen (LAD), Census 2021
Recorded severe mental illness prevalence is 1.4% (807 patients), exceeding England (1.0%), while learning disability prevalence is 0.7% (415 patients; England 0.6%). The PCN catchment contains 31 care homes with 1,040 beds, though bed capacity does not establish PCN registration. Higher recorded prevalence across these vulnerable cohorts and substantial catchment bed capacity may shape proactive care requirements.
Severe mental illness: physical health checks
SMI prevalence is 1.4% (807 patients; England 1.0%). Annual checks trail England: blood pressure is 77.9% (England 83.4%), BMI recording is 72.9% (England 82.1%), and alcohol recording is 73.3% (England 81.8%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
8,100
Hypertension register
+5.61%
Register growth, 3 yrs
Blackburn with Darwen (LAD) +4.97% · England +5.60%
−2.11pp
BP control, under 80
≤140/90 · −2.09pp aged 80+
+1,111
More patients by 2030
Forecast 9,211 (15.59%)
Hypertension case-finding and control
Hypertension recorded prevalence is 14.0% (8,100 patients), below Blackburn with Darwen (LAD) (15.0%), NHS Lancashire and South Cumbria Integrated Care Board (17.2%) and England (15.2%). Recent blood pressure checks reach 88.0% (England 90.0%). Hypertensive patients treated to target fell 3.5% over 2023 to 2025 (England +3.6%) to 64.5% (England 70.3%). Patients aged under 80 with blood pressure controlled to <= 140/90 mmHg fell 3.3% over 2023 to 2025 (England +3.2%) to 62.6% (England 67.8%).
Lipids and statins
Lipid-lowering therapy reaches 69.0% in QRISK >= 20% patients, exceeding England (63.6%), Blackburn with Darwen (LAD) (66.0%) and the ICB (61.4%). Statin therapy in diabetes with CVD reaches 89.0% (England 84.4%), and lipid lowering in CKD reaches 77.7% (England 70.3%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 103,575 | £1.60 | £1.64 | £1.86 | £165,720 |
| Cardiovascular (all), 2025 | 136,045 | £2.82 | £3.38 | £3.33 | £383,647 |
In 2026, the PCN prescribed 103,575 lipid-regulating items at £1.60 per item, below England (£1.86), Blackburn with Darwen (LAD) (£1.83) and the ICB (£1.64). Across these items, the PCN spends £26,930 less than at England's unit cost.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+1.54%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−1.77%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 8.5% (4,557 patients; England 6.6%), with 1,665 asthma management items prescribed per 1,000 aged 5-19 (England 1,488). Annual reviews reach 56.7% (England 65.7%), leaving about 2,000 unreviewed patients (1,972 calculated on the full register). Second-hand smoke recording for ages 6-19 is 65.2% (England 78.8%). COPD prevalence is 2.4% (1,373 patients; England 1.9%) with annual reviews at 72.5% (England 76.4%).
Cancer register and children's immunisation
Cancer prevalence is 2.5% (1,435 patients; England 3.8%). In Q1 2025/26, age-5 MMR dose 1 reached 96.3% (England 91.7%), but dose 2 fell 6.5 pp to 89.8% (England 82.8%; target 95.0%). The 4-in-1 booster reached 87.2% (England 80.9%; target 95.0%; denominator 187).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
In NHS Lancashire and South Cumbria ICB in 2022, 52.4% of staged cancers (4,642 of 8,863) were diagnosed at stage 1 or 2, trailing England (55.3%) and sitting 22.6 pp below the 75.0% national ambition. Cancers with a known stage accounted for 74.6% of registrations (8,863 of 11,883; England 67.0%). These ICB figures reflect system context, not PCN performance. At PCN level, cervical screening coverage aged 25-49 is 57.6% (England 66.8%), with a three-year change of -3.7% over 2023 to 2025 (England -1.0%). Breast screening reached 55.9% (England 69.9%) after rising +17.6% over 2023 to 2024 (England +8.4%).
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026 (provisional), East Lancashire Hospitals NHS Trust achieved 73.2% against the 85.0% 62-day referral to treatment standard (11.8 pp below standard), compared with 75.0% at Lancashire Teaching Hospitals NHS Foundation Trust, 69.7% at Bolton NHS Foundation Trust, 73.6% across NHS Lancashire and South Cumbria Integrated Care Board, and 71.2% in England. On the 28-day faster diagnosis standard (75.0% standard), East Lancashire Hospitals NHS Trust achieved 81.5%, compared with 78.4% across the ICB and 79.3% in England. These trust and ICB figures describe system performance, not PCN delivery.
| Pathways within standard (%) | East Lancashire | Lancashire | Bolton | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 81.50 | 82.90 | 80.48 | 78.39 | 79.32 |
| 31-day treatment (96%) | 98.11 | 89.43 | 96.50 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 73.16 | 75.04 | 69.66 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Lancashire | Lancashire | Bolton | England |
|---|---|---|---|---|
| MRI | 0.43 | 2.41 | 2.05 | 21.40 |
| CT | 0.15 | 14.97 | 19.40 | 9.92 |
| Echocardiography | 0.00 | 13.85 | 3.48 | 28.48 |
| Colonoscopy | 0.95 | 0.00 | 1.33 | 30.83 |
| Gastroscopy | 1.16 | 0.00 | 2.06 | 29.02 |
| All 15 DM01 tests | 3.25 | 26.65 | 15.78 | 23.14 |
| Community services activity | Blackburn With Darwen residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 535 | 193,720 |
| Referrals | 230 | 29,855 |
| Patients with a contact | 305 | 65,335 |
Community services (residents of Blackburn With Darwen), Jun 2026 (provisional). In Jun 2026 (provisional), community services data recorded 36.4% of contacts (195 of 535) among Blackburn with Darwen residents were with adults aged 65 and over. These figures capture local authority resident activity rather than PCN-level delivery, and borough-level contact shares do not establish practice-level community workload.
Practice variation and patient experience
Overall QOF achievement reached 82.1% to 94.1%, with a 32.5 pp range in vaccination
The England comparator for overall QOF achievement is 92.5%. The Cornerstone Practice achieved 82.1%. Roman Road Health Centre achieved 94.1%. In the vaccination and immunisation domain, the England comparator is 55.2%. William Hopwood Street Surgery achieved 15.6%, while Roman Road Health Centre achieved 48.1%, spanning a range of 32.5 pp between them.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Roman Road | 101 | 69.2 | 78.8% | 68.1% | 84.0% |
| Cornerstone | 108 | 71.3 | 41.6% | 76.9% | 78.4% |
| Pringle Street | 81 | 91.0 | 67.9% | 70.7% | 76.0% |
| St Georges Surgery | 109 | 50.1 | 66.2% | 67.7% | 75.4% |
| Bentham Road | 95 | 59.3 | 48.6% | 52.0% | 73.0% |
| William Hopwood | 101 | 92.5 | 56.2% | 59.7% | 72.8% |
| Stepping Stone | 93 | 90.1 | 58.6% | 77.5% | 65.3% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
20 of 25 three-year trends trail England despite improvements in diabetes control
Across 25 tracked three-year measures, 20 trail England's progress. The widest lags include heart failure reviews, which fell 9.3% (England +8.7%) to 67.2%, and smoking cessation offers, which fell 6.7 pp (England +0.1 pp) to 89.8%. Psychosis physical checks also lagged: alcohol recording fell 2.4 pp (England +5.4 pp) to 73.3%, and BMI recording fell 0.1 pp (England +5.1 pp) to 72.9%. In contrast, diabetes control without frailty improved +8.3% (England +4.4%) to 55.3%, and breast screening rose +17.6% over 2023 to 2024 (England +8.4%) to 55.9%.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Dementia register
Alcohol record (psychosis)
Hypertension treated to target
Smoking support (SMI)
Breast screening (53-70)
Diabetes HbA1c control
Diabetes statin (CVD)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackburn with Darwen (LAD) | Asset | PCN | Blackburn with Darwen (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 31 (1,040 beds) | n/a | Schools (catchment) | 109 | n/a |
| Children's centres | 10 | 13 | Places of worship | 74 | 99 |
| Libraries | 5 | 6 | Primary schools (LA maintained) | 37 | 45 |
| Primary academies | 7 | 6 | Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Standardise annual asthma review recall
Asthma review coverage is 56.7% (LAD 63.5%; England 65.7%), leaving 1,972 (about 2,000) of 4,557 registered patients without a review in the last 12 months. For discussion: practices could run a single-template recall audit, offer after-school slots, and combine inhaler checks with annual reviews. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Hypertension case-finding and titration recall
Hypertension prevalence is 14.0% (8,100 patients; LAD 15.0%; England 15.2%; unadjusted gap +588 to +734), and treatment to target fell 3.5% (England +3.6%) to 64.5% (England 70.3%). For discussion: practices could audit patients above target (62.6% aged <80 are <= 140/90 mmHg) for pharmacist titration and opportunistic checks. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 3
Heart failure register and review audit
Heart failure prevalence is 0.8% (458 patients; LAD 0.9%; England 1.1%; unadjusted gap +64 to +179), and annual reviews fell 9.3% (England +8.7%) to 67.2% (England 78.5%). For discussion: practices could search for uncoded discharges, standardise functional capacity templates, and run structured annual review recall. Moderate effort to run.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Culturally tailored access and recall (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Physical health check recall (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension treatment review (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool booster recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Standardise annual asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Hypertension case-finding and titration recall (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to target | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 3 · Heart failure register and review audit (p12) | Heart failure register · Heart Failure: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs) | — | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
